These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 3276623)
1. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Kochi SK; Johnson RC Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623 [TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296 [TBL] [Abstract][Full Text] [Related]
3. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. Kochi SK; Johnson RC; Dalmasso AP J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266 [TBL] [Abstract][Full Text] [Related]
4. Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments. Kochi SK; Johnson RC; Dalmasso AP Infect Immun; 1993 Jun; 61(6):2532-6. PubMed ID: 8500889 [TBL] [Abstract][Full Text] [Related]
5. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Des Prez RM; Bryan CS; Hawiger J; Colley DG Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523 [TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128 [TBL] [Abstract][Full Text] [Related]
7. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer. Nelson DR; Rooney S; Miller NJ; Mather TN J Parasitol; 2000 Dec; 86(6):1232-8. PubMed ID: 11191897 [TBL] [Abstract][Full Text] [Related]
8. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Jarvis GA; Vedros NA Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of mammalian and reptilian alternative pathway of complement-mediated killing of the Lyme disease spirochete (Borrelia burgdorferi). Kuo MM; Lane RS; Giclas PC J Parasitol; 2000 Dec; 86(6):1223-8. PubMed ID: 11191895 [TBL] [Abstract][Full Text] [Related]
10. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580 [TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
12. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH. Gronski P; Bodenbender L; Kanzy EJ; Seiler FR Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396 [TBL] [Abstract][Full Text] [Related]
13. Differences of two Borrelia burgdorferi strains in complement activation and serum resistance. Brade V; Kleber I; Acker G Immunobiology; 1992 Sep; 185(5):453-65. PubMed ID: 1452216 [TBL] [Abstract][Full Text] [Related]
14. The Classical Complement Pathway Is Required to Control Zhi H; Xie J; Skare JT Front Immunol; 2018; 9():959. PubMed ID: 29867944 [TBL] [Abstract][Full Text] [Related]
15. Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components. Schwab J; Hammerschmidt C; Richter D; Skerka C; Matuschka FR; Wallich R; Zipfel PF; Kraiczy P PLoS One; 2013; 8(1):e53659. PubMed ID: 23320099 [TBL] [Abstract][Full Text] [Related]
16. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B. Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651 [TBL] [Abstract][Full Text] [Related]
17. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody. Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738 [TBL] [Abstract][Full Text] [Related]
18. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae. Densen P; McRill CM; Ross SC J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507 [TBL] [Abstract][Full Text] [Related]
19. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL; Duncan RL; Morrison DC J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676 [TBL] [Abstract][Full Text] [Related]
20. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci. Payne NR; Kim YK; Ferrieri P Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]